tiprankstipranks
Advertisement
Advertisement
PTC Therapeutics price target raised to $109 from $106 at Wells Fargo
PremiumThe FlyPTC Therapeutics price target raised to $109 from $106 at Wells Fargo
20d ago
PTC Therapeutics price target raised to $122 from $120 at Barclays
Premium
The Fly
PTC Therapeutics price target raised to $122 from $120 at Barclays
21d ago
PTC Therapeutics Sets Up Long-Term FA Study, Adding a New Catalyst for PTCT Investors
Premium
Company Announcements
PTC Therapeutics Sets Up Long-Term FA Study, Adding a New Catalyst for PTCT Investors
23d ago
PTC Therapeutics Raises Outlook on Strong Q2 Results
PremiumCompany AnnouncementsPTC Therapeutics Raises Outlook on Strong Q2 Results
1M ago
PTC Therapeutics reports Q2 EPS 92c, consensus 34c
Premium
The Fly
PTC Therapeutics reports Q2 EPS 92c, consensus 34c
1M ago
PTC Therapeutics raises 2026 revenue view to $1.18B-$1.28B from $1.08B-$1.18B
Premium
The Fly
PTC Therapeutics raises 2026 revenue view to $1.18B-$1.28B from $1.08B-$1.18B
1M ago
PTC Therapeutics price target raised to $91 from $89 at JPMorgan
PremiumThe FlyPTC Therapeutics price target raised to $91 from $89 at JPMorgan
2M ago
PTC Therapeutics price target raised to $85 from $82 at RBC Capital
Premium
The Fly
PTC Therapeutics price target raised to $85 from $82 at RBC Capital
2M ago
Citizens biotech analysts hold an analyst/industry conference call
Premium
The Fly
Citizens biotech analysts hold an analyst/industry conference call
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100